LS22, Inc. — Form D/A

LS22, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2018-02-09. The offering totals $11.4M, of which $11.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (42)

Showing 25 of 42 people.

NameRoleLocation
Robert NelsenDirectorSeattle, WA
Sanj A PatelDirectorCambridge, MA
Vicki SatoDirectorSan Francisco, CA
Eric A OlsonExecutive OfficerCambridge, MA
Gerald A QuirkExecutive OfficerCambridge, MA
David A RothExecutive OfficerDenver, CO
Jeremy A SpringhornExecutive OfficerCambridge, MA
Srinivas AkkarajuDirectorPalo Alto, CA
Mark AllesDirectorCulver City, CA
Sue Gail EckhardtDirectorCambridge, MA
Timothy C TysonDirectorCambridge, MA
Deborah DunsireDirectorCambridge, MA
Kristin C StephensExecutive OfficerCambridge, MA
Conely C CheeExecutive OfficerCambridge, MA
Eric C OlsonExecutive OfficerCambridge, MA
Marsha A FanucciDirectorCambridge, MA
David C RothExecutive OfficerCambridge, MA
Peter WirthDirectorCambridge, MA
Nancy SimonianDirectorCambridge, MA
Nancy SimonianExecutive OfficerCambridge, MA
Jason C HaasExecutive OfficerCambridge, MA
Andrew C OhDirectorCambridge, MA
AMIR NASHATDirectorSan Diego, CA
JORGE CONDEExecutive OfficerCAMBRIDGE, MA
Philip SharpDirectorCambridge, MA

Other filings by this issuer (6)

FiledFormOfferingSold
2022-09-21D$129.8M$129.8M
2020-12-17D$121.6M$90.5M
2018-01-17D$10.0M$10.0M
2014-10-24D$53.1M$53.1M
2013-04-22D$12.0M$10.0M
2012-08-22D$1.3M$1.3M

More